tradingkey.logo

BUZZ-India's Shalby gains on US FDA approval for knee replacement device

ReutersJan 16, 2025 4:31 AM

Shares of hospital chain operator Shalby SHAY.NS rise as much as 4.9% to 233.65 rupees; currently up 2.6%

Co on Wednesday said its U.S. unit received U.S. FDA clearance for DuraniomTM, its primary total knee replacement device

Stock on track for a third consecutive session of gains, if trend holds

SHAY fell 24.1% in 2024, snapping four straight years of gains

(Reporting by Ashish Chandra in Bengaluru)

((ashish.chandra@thomsonreuters.com (+91 7982114624))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI